Get the latest news, insights, and market updates on KRMD (KORU Medical Systems, Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
3 Stocks Estimated To Be Trading Below Their Intrinsic Value In November 2025
In the current climate of mixed market performance, with the Dow Jones Industrial Average experiencing fluctuations and tech stocks facing valuation concerns, investors are keenly observing opportunities for potential undervalued assets. As we explore three stocks estimated to be trading below their intrinsic value in November 2025, understanding what constitutes a good investment becomes crucial—particularly in identifying companies that may offer strong fundamentals and growth potential... Nov 17, 2025 - $KRMD
KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025
MAHWAH, N.J., November 17, 2025--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will present its latest research at the ESID/EHA/SIOPE Focused Symposium 2025 in Vienna, Austria, November 18-20. The poster presentation, titled "Comparing Mechanical Pump and Manual Push for Short-Duration Subcutaneous Infusions: Nov 17, 2025 - $KRMD
Alto Ingredients And 2 Other Penny Stocks To Watch Closely
As the U.S. stock market experiences a sharp downturn, with major indices like the Dow Jones and Nasdaq seeing significant losses, investors are evaluating their portfolios in search of resilient opportunities. Amidst this volatility, penny stocks—often smaller or newer companies—remain an intriguing investment category due to their potential for growth and affordability. Despite being considered a somewhat outdated term, penny stocks can still offer compelling prospects when backed by strong... Nov 14, 2025 - $KRMD
KORU Medical Systems to Participate in Upcoming Investor Conferences
MAHWAH, N.J., November 13, 2025--KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will be participating in three upcoming Investor Conferences. Nov 13, 2025 - $KRMD
KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance
MAHWAH, N.J., November 12, 2025--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the third quarter ended September 30, 2025. Nov 12, 2025 - $KRMD
KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems
MAHWAH, N.J., November 04, 2025--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use patient-centric large volume subcutaneous infusion solutions, today announced a development agreement with a global pharmaceutical company. The agreement allows for broad collaboration on next-generation infusion systems in subcutaneous immunoglobulin (SCIg) Nov 4, 2025 - $KRMD
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" lets us enhance your experience and provide personalized content and ads.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple